Zach Baca is an investment analyst in the Global Equity Division, covering stocks in the biotech area. He is an Investment Advisory Committee member of the Health Sciences Equity Strategy. Zach is a vice president of T. Rowe Price Associates, Inc.

Zach’s investment experience began in 2014, and he has been with T. Rowe Price since 2019, beginning in the U.S. Equity Division. Prior to this, Zach was employed by Rock Springs Capital, a health care-focused hedge fund, as an associate. He also was employed by Burns McClellan as an account executive.

Zach earned a B.A. with a double major in economics and history from Williams College.